Profound Medical Corp.
PRN.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.25% | 14.83% | -126.84% | -62.85% | 42.90% |
| Total Depreciation and Amortization | -54.20% | -31.31% | -39.74% | -34.80% | 190.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 174.30% | 151.05% | 77.61% | 19.95% | -42.76% |
| Change in Net Operating Assets | 107.36% | -307.83% | 205.48% | 31.72% | -545.87% |
| Cash from Operations | -11.69% | -40.84% | -121.00% | -82.89% | 19.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | 53.45% | -265.02% |
| Issuance of Common Stock | 8.24% | -- | -- | -- | 980,200.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.53% | -- | -- | -- | -- |
| Cash from Financing | 16.91% | 100.00% | 100.00% | -101.42% | 17,906.53% |
| Foreign Exchange rate Adjustments | 115.68% | -263.42% | 998.21% | 109.79% | -1,623.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.58% | -49.07% | -58.26% | -156.65% | 474.92% |